Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Scientists develop an extremely potent siRNA with broad activity against SARS-CoVs

Researchers in Germany have developed a promising approach to suppressing the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

12 Oct 2021

Prescriptions for prenatal substance use disorder treatment fell in US during COVID-19 pandemic

Researchers have shown that the number of prescriptions filled out for a treatment associated with improved pregnancy outcomes among individuals with substance use disorder declined in the United States as the coronavirus disease 2019 (COVID-19) pandemic continued.

12 Oct 2021

New eco-friendly solution to fight against malaria

Mosquitoes can and do feed on HMBPP-supplemented beetroot juice. This is the findings of a study at Stockholm University.

12 Oct 2021

Research finds county-level differences in COVID outcomes based on college policy

A recent study panalyzes the number of SARS-CoV-2 infections and related deaths in education campuses.

12 Oct 2021

Rapid measurement of SARS-CoV-2 spike T-cells

Researchers measure SARS-CoV-2 T-cell responses in individuals vaccinated or in those who developed immunity from a prior natural infection.

12 Oct 2021

A survey on computational methods in discovering protein inhibitors of SARS-CoV-2

Researchers review diverse computational methods for drug/inhibitor design and enzymes as potential targets for inhibitors to treat coronaviruses diseases.

12 Oct 2021

New modeling highlights the role of socio-economic status in Covid-19 transmission in Kenya

Combining data on antibody prevalence, PCR test results, genomic surveillance and population mobility from smartphones has allowed infectious disease modelers to explain the evolution of the first three Covid-19 waves that have affected Kenya since the start of the pandemic.

12 Oct 2021

A mucoadhesive polymer with anti-SARS-COV-2 activity in vitro and in vivo

The team has evaluated a low molecular weight chitosan derivative as a candidate preventing the viral entry into mammalian nasal epithelial cells to limit the spread of COVID-19.

12 Oct 2021

Typhoid vaccine found to be 84% effective in preventing the disease in children

A vaccine has proved safe and effective in protecting children against typhoid, raising hopes of fighting the disease in Sub-Saharan Africa, a study says.

12 Oct 2021

Taste loss as a COVID-19 symptom: a review

A new review reports that alterations in taste affected about a third of individuals with a COVID-19 diagnosis, with females being affected more than males.

12 Oct 2021

Vaccinated children induced significantly higher antibody titers than naturally SARS-CoV-2 infected children

A recent preprint discusses the antibody response to the nucleic acid vaccines against SARS-CoV-2 when administered to children aged 7-11 years.

12 Oct 2021

Novel vaccine demonstrates high efficacy for prevention of COVID-19

The clinical trial studied the efficacy of Novavax’s COVID-19 vaccine, NVX-CoV2373, and found it highly effective in preventing mild, moderate, and severe COVID-19 after full vaccination.

12 Oct 2021

COVID-19 vaccine effectiveness in New York state

A new preprint assessed vaccine effectiveness in 8.8 million people in New York six months after vaccination.

12 Oct 2021

Development of disinfection process based on ozone for highly efficient inactivation of SARS-CoV-2

This study aimed to evaluate the ozone capacity generated within a newly developed disinfection chamber to eradicate SARS-CoV-2 from porous materials and non-porous materials like glass.

12 Oct 2021

Research reveals components of Sinbis virus ribonucleoproteins

To address this gap in research regarding the understanding of post-replicative alphavirus RNPs, scientists have created a novel proteome-wide approach known as viral RNA interactome capture (vRIC). This study is available in the bioRxiv* preprint server while awaiting peer review.

11 Oct 2021

A new bacterial two-hybrid assay to study SARS-CoV-2 interactome

Recently, scientists have developed a bacterial two-hybrid (B2H) system to study the PPIs of SARS-CoV-2 in a heterologous non-eukaryotic system. This study is available on the bioRxiv* preprint server. Put simply, the B2H system could be used to analyze the SARS-CoV-2 proteome.

11 Oct 2021

Democrat-led state governments took stricter measures and have seen lower rate of COVID-19 spread

States with Democratic leaders tended to have responded more strongly to COVID-19 and have seen a lower rate of the spread of the virus, according to new research led by faculty at Binghamton University, State University of New York.

11 Oct 2021

New compound can prevent SARS-CoV-2 and related coronaviruses from entering cells

Scientists at Washington University School of Medicine in St. Louis have developed a compound that prevents SARS-CoV-2 and related coronaviruses from entering cells.

11 Oct 2021

Study suggests less access to nature may contribute to higher COVID-19 case rates

By now, it's clear the COVID-19 pandemic has been particularly unkind to communities of color and low-income populations.

11 Oct 2021

Delta SARS-CoV-2 variant does not make kids sicker than Alpha, study finds

Children are not at risk for more severe COVID-19 disease with Delta compared to earlier severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, finds a new medRxiv* preprint study. In the first large-scale epidemiological study comparing SARS-CoV-2 infection between variants in children, researchers found children were more likely to be as sick from Delta as they would be if they were infected with the Alpha variant.

11 Oct 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Scientists develop an extremely potent siRNA with broad activity against SARS-CoVs

Prescriptions for prenatal substance use disorder treatment fell in US during COVID-19 pandemic

New eco-friendly solution to fight against malaria

Research finds county-level differences in COVID outcomes based on college policy

Rapid measurement of SARS-CoV-2 spike T-cells

A survey on computational methods in discovering protein inhibitors of SARS-CoV-2

New modeling highlights the role of socio-economic status in Covid-19 transmission in Kenya

A mucoadhesive polymer with anti-SARS-COV-2 activity in vitro and in vivo

Typhoid vaccine found to be 84% effective in preventing the disease in children

Taste loss as a COVID-19 symptom: a review

Vaccinated children induced significantly higher antibody titers than naturally SARS-CoV-2 infected children

Novel vaccine demonstrates high efficacy for prevention of COVID-19

COVID-19 vaccine effectiveness in New York state

Development of disinfection process based on ozone for highly efficient inactivation of SARS-CoV-2

Research reveals components of Sinbis virus ribonucleoproteins

A new bacterial two-hybrid assay to study SARS-CoV-2 interactome

Democrat-led state governments took stricter measures and have seen lower rate of COVID-19 spread

New compound can prevent SARS-CoV-2 and related coronaviruses from entering cells

Study suggests less access to nature may contribute to higher COVID-19 case rates

Delta SARS-CoV-2 variant does not make kids sicker than Alpha, study finds

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in